Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/1704291.pdf
Reference35 articles.
1. Curtis RE, Boice JD, Moloney WC et al. Leukemia following chemotherapy for breast cancer. Cancer Res 1990; 50: 2741–2746.
2. Curtis RE, Boice Jr JD, Stovall M et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992; 326: 1745–1751.
3. Fisher B, Rockette H, Fisher ER et al. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol 1985; 12: 1640–1658.
4. LeBeau MM, Albain KS, Larson RA et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no 5 and 7. J Clin Oncol 1986; 4: 325–345.
5. Felix CA . Secondary leukemias induced by topoisomerase-targeted drugs. Biochem Biophys Acta 1998; 1400: 233–255.
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current trends and challenges in the mitoxantrone measuring in biofluids and new pharmaceutical systems;TrAC Trends in Analytical Chemistry;2023-12
2. Encapsulation of pixantrone into PEGylated liposomes enhances its antineoplastic efficacy and reduces thymus toxicity;Journal of Drug Delivery Science and Technology;2023-09
3. Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer;Haematologica;2022-06-30
4. Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic;TURKISH JOURNAL OF MEDICAL SCIENCES;2021
5. Getting Lost in the Cell–Lysosomal Entrapment of Chemotherapeutics;Cancers;2020-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3